Global Celecoxib Market Research Report 2024(Status and Outlook)
Report Overview:
Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.
The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.
The Global Celecoxib Market Size was estimated at USD 1390.06 million in 2023 and is projected to reach USD 2255.33 million by 2029, exhibiting a CAGR of 8.40% during the forecast period.
This report provides a deep insight into the global Celecoxib market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Celecoxib Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Celecoxib market in any manner.
Global Celecoxib Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer Inc
Teva
Mylan
Apotex
Lupin
Hengrui Medicine
Market Segmentation (by Type)
50mg
100mg
200mg
400mg
Market Segmentation (by Application)
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other diseases
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Celecoxib Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.
The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.
The Global Celecoxib Market Size was estimated at USD 1390.06 million in 2023 and is projected to reach USD 2255.33 million by 2029, exhibiting a CAGR of 8.40% during the forecast period.
This report provides a deep insight into the global Celecoxib market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Celecoxib Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Celecoxib market in any manner.
Global Celecoxib Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer Inc
Teva
Mylan
Apotex
Lupin
Hengrui Medicine
Market Segmentation (by Type)
50mg
100mg
200mg
400mg
Market Segmentation (by Application)
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other diseases
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Celecoxib Market
- Overview of the regional outlook of the Celecoxib Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Celecoxib Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Celecoxib
1.2 Key Market Segments
1.2.1 Celecoxib Segment by Type
1.2.2 Celecoxib Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELECOXIB MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Celecoxib Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Celecoxib Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELECOXIB MARKET COMPETITIVE LANDSCAPE
3.1 Global Celecoxib Sales by Manufacturers (2019-2024)
3.2 Global Celecoxib Revenue Market Share by Manufacturers (2019-2024)
3.3 Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Celecoxib Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Celecoxib Sales Sites, Area Served, Product Type
3.6 Celecoxib Market Competitive Situation and Trends
3.6.1 Celecoxib Market Concentration Rate
3.6.2 Global 5 and 10 Largest Celecoxib Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELECOXIB INDUSTRY CHAIN ANALYSIS
4.1 Celecoxib Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELECOXIB MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELECOXIB MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Celecoxib Sales Market Share by Type (2019-2024)
6.3 Global Celecoxib Market Size Market Share by Type (2019-2024)
6.4 Global Celecoxib Price by Type (2019-2024)
7 CELECOXIB MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Celecoxib Market Sales by Application (2019-2024)
7.3 Global Celecoxib Market Size (M USD) by Application (2019-2024)
7.4 Global Celecoxib Sales Growth Rate by Application (2019-2024)
8 CELECOXIB MARKET SEGMENTATION BY REGION
8.1 Global Celecoxib Sales by Region
8.1.1 Global Celecoxib Sales by Region
8.1.2 Global Celecoxib Sales Market Share by Region
8.2 North America
8.2.1 North America Celecoxib Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Celecoxib Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Celecoxib Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Celecoxib Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Celecoxib Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer Inc
9.1.1 Pfizer Inc Celecoxib Basic Information
9.1.2 Pfizer Inc Celecoxib Product Overview
9.1.3 Pfizer Inc Celecoxib Product Market Performance
9.1.4 Pfizer Inc Business Overview
9.1.5 Pfizer Inc Celecoxib SWOT Analysis
9.1.6 Pfizer Inc Recent Developments
9.2 Teva
9.2.1 Teva Celecoxib Basic Information
9.2.2 Teva Celecoxib Product Overview
9.2.3 Teva Celecoxib Product Market Performance
9.2.4 Teva Business Overview
9.2.5 Teva Celecoxib SWOT Analysis
9.2.6 Teva Recent Developments
9.3 Mylan
9.3.1 Mylan Celecoxib Basic Information
9.3.2 Mylan Celecoxib Product Overview
9.3.3 Mylan Celecoxib Product Market Performance
9.3.4 Mylan Celecoxib SWOT Analysis
9.3.5 Mylan Business Overview
9.3.6 Mylan Recent Developments
9.4 Apotex
9.4.1 Apotex Celecoxib Basic Information
9.4.2 Apotex Celecoxib Product Overview
9.4.3 Apotex Celecoxib Product Market Performance
9.4.4 Apotex Business Overview
9.4.5 Apotex Recent Developments
9.5 Lupin
9.5.1 Lupin Celecoxib Basic Information
9.5.2 Lupin Celecoxib Product Overview
9.5.3 Lupin Celecoxib Product Market Performance
9.5.4 Lupin Business Overview
9.5.5 Lupin Recent Developments
9.6 Hengrui Medicine
9.6.1 Hengrui Medicine Celecoxib Basic Information
9.6.2 Hengrui Medicine Celecoxib Product Overview
9.6.3 Hengrui Medicine Celecoxib Product Market Performance
9.6.4 Hengrui Medicine Business Overview
9.6.5 Hengrui Medicine Recent Developments
10 CELECOXIB MARKET FORECAST BY REGION
10.1 Global Celecoxib Market Size Forecast
10.2 Global Celecoxib Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Celecoxib Market Size Forecast by Country
10.2.3 Asia Pacific Celecoxib Market Size Forecast by Region
10.2.4 South America Celecoxib Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Celecoxib by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Celecoxib Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Celecoxib by Type (2025-2030)
11.1.2 Global Celecoxib Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Celecoxib by Type (2025-2030)
11.2 Global Celecoxib Market Forecast by Application (2025-2030)
11.2.1 Global Celecoxib Sales (Kilotons) Forecast by Application
11.2.2 Global Celecoxib Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Celecoxib
1.2 Key Market Segments
1.2.1 Celecoxib Segment by Type
1.2.2 Celecoxib Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELECOXIB MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Celecoxib Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Celecoxib Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELECOXIB MARKET COMPETITIVE LANDSCAPE
3.1 Global Celecoxib Sales by Manufacturers (2019-2024)
3.2 Global Celecoxib Revenue Market Share by Manufacturers (2019-2024)
3.3 Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Celecoxib Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Celecoxib Sales Sites, Area Served, Product Type
3.6 Celecoxib Market Competitive Situation and Trends
3.6.1 Celecoxib Market Concentration Rate
3.6.2 Global 5 and 10 Largest Celecoxib Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELECOXIB INDUSTRY CHAIN ANALYSIS
4.1 Celecoxib Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELECOXIB MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELECOXIB MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Celecoxib Sales Market Share by Type (2019-2024)
6.3 Global Celecoxib Market Size Market Share by Type (2019-2024)
6.4 Global Celecoxib Price by Type (2019-2024)
7 CELECOXIB MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Celecoxib Market Sales by Application (2019-2024)
7.3 Global Celecoxib Market Size (M USD) by Application (2019-2024)
7.4 Global Celecoxib Sales Growth Rate by Application (2019-2024)
8 CELECOXIB MARKET SEGMENTATION BY REGION
8.1 Global Celecoxib Sales by Region
8.1.1 Global Celecoxib Sales by Region
8.1.2 Global Celecoxib Sales Market Share by Region
8.2 North America
8.2.1 North America Celecoxib Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Celecoxib Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Celecoxib Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Celecoxib Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Celecoxib Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer Inc
9.1.1 Pfizer Inc Celecoxib Basic Information
9.1.2 Pfizer Inc Celecoxib Product Overview
9.1.3 Pfizer Inc Celecoxib Product Market Performance
9.1.4 Pfizer Inc Business Overview
9.1.5 Pfizer Inc Celecoxib SWOT Analysis
9.1.6 Pfizer Inc Recent Developments
9.2 Teva
9.2.1 Teva Celecoxib Basic Information
9.2.2 Teva Celecoxib Product Overview
9.2.3 Teva Celecoxib Product Market Performance
9.2.4 Teva Business Overview
9.2.5 Teva Celecoxib SWOT Analysis
9.2.6 Teva Recent Developments
9.3 Mylan
9.3.1 Mylan Celecoxib Basic Information
9.3.2 Mylan Celecoxib Product Overview
9.3.3 Mylan Celecoxib Product Market Performance
9.3.4 Mylan Celecoxib SWOT Analysis
9.3.5 Mylan Business Overview
9.3.6 Mylan Recent Developments
9.4 Apotex
9.4.1 Apotex Celecoxib Basic Information
9.4.2 Apotex Celecoxib Product Overview
9.4.3 Apotex Celecoxib Product Market Performance
9.4.4 Apotex Business Overview
9.4.5 Apotex Recent Developments
9.5 Lupin
9.5.1 Lupin Celecoxib Basic Information
9.5.2 Lupin Celecoxib Product Overview
9.5.3 Lupin Celecoxib Product Market Performance
9.5.4 Lupin Business Overview
9.5.5 Lupin Recent Developments
9.6 Hengrui Medicine
9.6.1 Hengrui Medicine Celecoxib Basic Information
9.6.2 Hengrui Medicine Celecoxib Product Overview
9.6.3 Hengrui Medicine Celecoxib Product Market Performance
9.6.4 Hengrui Medicine Business Overview
9.6.5 Hengrui Medicine Recent Developments
10 CELECOXIB MARKET FORECAST BY REGION
10.1 Global Celecoxib Market Size Forecast
10.2 Global Celecoxib Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Celecoxib Market Size Forecast by Country
10.2.3 Asia Pacific Celecoxib Market Size Forecast by Region
10.2.4 South America Celecoxib Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Celecoxib by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Celecoxib Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Celecoxib by Type (2025-2030)
11.1.2 Global Celecoxib Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Celecoxib by Type (2025-2030)
11.2 Global Celecoxib Market Forecast by Application (2025-2030)
11.2.1 Global Celecoxib Sales (Kilotons) Forecast by Application
11.2.2 Global Celecoxib Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Celecoxib Market Size Comparison by Region (M USD)
Table 5. Global Celecoxib Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Celecoxib Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Celecoxib Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Celecoxib Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib as of 2022)
Table 10. Global Market Celecoxib Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Celecoxib Sales Sites and Area Served
Table 12. Manufacturers Celecoxib Product Type
Table 13. Global Celecoxib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Celecoxib
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Celecoxib Market Challenges
Table 22. Global Celecoxib Sales by Type (Kilotons)
Table 23. Global Celecoxib Market Size by Type (M USD)
Table 24. Global Celecoxib Sales (Kilotons) by Type (2019-2024)
Table 25. Global Celecoxib Sales Market Share by Type (2019-2024)
Table 26. Global Celecoxib Market Size (M USD) by Type (2019-2024)
Table 27. Global Celecoxib Market Size Share by Type (2019-2024)
Table 28. Global Celecoxib Price (USD/Ton) by Type (2019-2024)
Table 29. Global Celecoxib Sales (Kilotons) by Application
Table 30. Global Celecoxib Market Size by Application
Table 31. Global Celecoxib Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Celecoxib Sales Market Share by Application (2019-2024)
Table 33. Global Celecoxib Sales by Application (2019-2024) & (M USD)
Table 34. Global Celecoxib Market Share by Application (2019-2024)
Table 35. Global Celecoxib Sales Growth Rate by Application (2019-2024)
Table 36. Global Celecoxib Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Celecoxib Sales Market Share by Region (2019-2024)
Table 38. North America Celecoxib Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Celecoxib Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Celecoxib Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Celecoxib Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Celecoxib Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Inc Celecoxib Basic Information
Table 44. Pfizer Inc Celecoxib Product Overview
Table 45. Pfizer Inc Celecoxib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Inc Business Overview
Table 47. Pfizer Inc Celecoxib SWOT Analysis
Table 48. Pfizer Inc Recent Developments
Table 49. Teva Celecoxib Basic Information
Table 50. Teva Celecoxib Product Overview
Table 51. Teva Celecoxib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Teva Business Overview
Table 53. Teva Celecoxib SWOT Analysis
Table 54. Teva Recent Developments
Table 55. Mylan Celecoxib Basic Information
Table 56. Mylan Celecoxib Product Overview
Table 57. Mylan Celecoxib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Mylan Celecoxib SWOT Analysis
Table 59. Mylan Business Overview
Table 60. Mylan Recent Developments
Table 61. Apotex Celecoxib Basic Information
Table 62. Apotex Celecoxib Product Overview
Table 63. Apotex Celecoxib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Apotex Business Overview
Table 65. Apotex Recent Developments
Table 66. Lupin Celecoxib Basic Information
Table 67. Lupin Celecoxib Product Overview
Table 68. Lupin Celecoxib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Lupin Business Overview
Table 70. Lupin Recent Developments
Table 71. Hengrui Medicine Celecoxib Basic Information
Table 72. Hengrui Medicine Celecoxib Product Overview
Table 73. Hengrui Medicine Celecoxib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Hengrui Medicine Business Overview
Table 75. Hengrui Medicine Recent Developments
Table 76. Global Celecoxib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 77. Global Celecoxib Market Size Forecast by Region (2025-2030) & (M USD)
Table 78. North America Celecoxib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 79. North America Celecoxib Market Size Forecast by Country (2025-2030) & (M USD)
Table 80. Europe Celecoxib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 81. Europe Celecoxib Market Size Forecast by Country (2025-2030) & (M USD)
Table 82. Asia Pacific Celecoxib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 83. Asia Pacific Celecoxib Market Size Forecast by Region (2025-2030) & (M USD)
Table 84. South America Celecoxib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 85. South America Celecoxib Market Size Forecast by Country (2025-2030) & (M USD)
Table 86. Middle East and Africa Celecoxib Consumption Forecast by Country (2025-2030) & (Units)
Table 87. Middle East and Africa Celecoxib Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Global Celecoxib Sales Forecast by Type (2025-2030) & (Kilotons)
Table 89. Global Celecoxib Market Size Forecast by Type (2025-2030) & (M USD)
Table 90. Global Celecoxib Price Forecast by Type (2025-2030) & (USD/Ton)
Table 91. Global Celecoxib Sales (Kilotons) Forecast by Application (2025-2030)
Table 92. Global Celecoxib Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Celecoxib Market Size Comparison by Region (M USD)
Table 5. Global Celecoxib Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Celecoxib Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Celecoxib Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Celecoxib Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib as of 2022)
Table 10. Global Market Celecoxib Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Celecoxib Sales Sites and Area Served
Table 12. Manufacturers Celecoxib Product Type
Table 13. Global Celecoxib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Celecoxib
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Celecoxib Market Challenges
Table 22. Global Celecoxib Sales by Type (Kilotons)
Table 23. Global Celecoxib Market Size by Type (M USD)
Table 24. Global Celecoxib Sales (Kilotons) by Type (2019-2024)
Table 25. Global Celecoxib Sales Market Share by Type (2019-2024)
Table 26. Global Celecoxib Market Size (M USD) by Type (2019-2024)
Table 27. Global Celecoxib Market Size Share by Type (2019-2024)
Table 28. Global Celecoxib Price (USD/Ton) by Type (2019-2024)
Table 29. Global Celecoxib Sales (Kilotons) by Application
Table 30. Global Celecoxib Market Size by Application
Table 31. Global Celecoxib Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Celecoxib Sales Market Share by Application (2019-2024)
Table 33. Global Celecoxib Sales by Application (2019-2024) & (M USD)
Table 34. Global Celecoxib Market Share by Application (2019-2024)
Table 35. Global Celecoxib Sales Growth Rate by Application (2019-2024)
Table 36. Global Celecoxib Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Celecoxib Sales Market Share by Region (2019-2024)
Table 38. North America Celecoxib Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Celecoxib Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Celecoxib Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Celecoxib Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Celecoxib Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Inc Celecoxib Basic Information
Table 44. Pfizer Inc Celecoxib Product Overview
Table 45. Pfizer Inc Celecoxib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Inc Business Overview
Table 47. Pfizer Inc Celecoxib SWOT Analysis
Table 48. Pfizer Inc Recent Developments
Table 49. Teva Celecoxib Basic Information
Table 50. Teva Celecoxib Product Overview
Table 51. Teva Celecoxib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Teva Business Overview
Table 53. Teva Celecoxib SWOT Analysis
Table 54. Teva Recent Developments
Table 55. Mylan Celecoxib Basic Information
Table 56. Mylan Celecoxib Product Overview
Table 57. Mylan Celecoxib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Mylan Celecoxib SWOT Analysis
Table 59. Mylan Business Overview
Table 60. Mylan Recent Developments
Table 61. Apotex Celecoxib Basic Information
Table 62. Apotex Celecoxib Product Overview
Table 63. Apotex Celecoxib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Apotex Business Overview
Table 65. Apotex Recent Developments
Table 66. Lupin Celecoxib Basic Information
Table 67. Lupin Celecoxib Product Overview
Table 68. Lupin Celecoxib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Lupin Business Overview
Table 70. Lupin Recent Developments
Table 71. Hengrui Medicine Celecoxib Basic Information
Table 72. Hengrui Medicine Celecoxib Product Overview
Table 73. Hengrui Medicine Celecoxib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Hengrui Medicine Business Overview
Table 75. Hengrui Medicine Recent Developments
Table 76. Global Celecoxib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 77. Global Celecoxib Market Size Forecast by Region (2025-2030) & (M USD)
Table 78. North America Celecoxib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 79. North America Celecoxib Market Size Forecast by Country (2025-2030) & (M USD)
Table 80. Europe Celecoxib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 81. Europe Celecoxib Market Size Forecast by Country (2025-2030) & (M USD)
Table 82. Asia Pacific Celecoxib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 83. Asia Pacific Celecoxib Market Size Forecast by Region (2025-2030) & (M USD)
Table 84. South America Celecoxib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 85. South America Celecoxib Market Size Forecast by Country (2025-2030) & (M USD)
Table 86. Middle East and Africa Celecoxib Consumption Forecast by Country (2025-2030) & (Units)
Table 87. Middle East and Africa Celecoxib Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Global Celecoxib Sales Forecast by Type (2025-2030) & (Kilotons)
Table 89. Global Celecoxib Market Size Forecast by Type (2025-2030) & (M USD)
Table 90. Global Celecoxib Price Forecast by Type (2025-2030) & (USD/Ton)
Table 91. Global Celecoxib Sales (Kilotons) Forecast by Application (2025-2030)
Table 92. Global Celecoxib Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Celecoxib
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Celecoxib Market Size (M USD), 2019-2030
Figure 5. Global Celecoxib Market Size (M USD) (2019-2030)
Figure 6. Global Celecoxib Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Celecoxib Market Size by Country (M USD)
Figure 11. Celecoxib Sales Share by Manufacturers in 2023
Figure 12. Global Celecoxib Revenue Share by Manufacturers in 2023
Figure 13. Celecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Celecoxib Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Celecoxib Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Celecoxib Market Share by Type
Figure 18. Sales Market Share of Celecoxib by Type (2019-2024)
Figure 19. Sales Market Share of Celecoxib by Type in 2023
Figure 20. Market Size Share of Celecoxib by Type (2019-2024)
Figure 21. Market Size Market Share of Celecoxib by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Celecoxib Market Share by Application
Figure 24. Global Celecoxib Sales Market Share by Application (2019-2024)
Figure 25. Global Celecoxib Sales Market Share by Application in 2023
Figure 26. Global Celecoxib Market Share by Application (2019-2024)
Figure 27. Global Celecoxib Market Share by Application in 2023
Figure 28. Global Celecoxib Sales Growth Rate by Application (2019-2024)
Figure 29. Global Celecoxib Sales Market Share by Region (2019-2024)
Figure 30. North America Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Celecoxib Sales Market Share by Country in 2023
Figure 32. U.S. Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Celecoxib Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Celecoxib Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Celecoxib Sales Market Share by Country in 2023
Figure 37. Germany Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Celecoxib Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Celecoxib Sales Market Share by Region in 2023
Figure 44. China Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Celecoxib Sales and Growth Rate (Kilotons)
Figure 50. South America Celecoxib Sales Market Share by Country in 2023
Figure 51. Brazil Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Celecoxib Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Celecoxib Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Celecoxib Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Celecoxib Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Celecoxib Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Celecoxib Market Share Forecast by Type (2025-2030)
Figure 65. Global Celecoxib Sales Forecast by Application (2025-2030)
Figure 66. Global Celecoxib Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Celecoxib
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Celecoxib Market Size (M USD), 2019-2030
Figure 5. Global Celecoxib Market Size (M USD) (2019-2030)
Figure 6. Global Celecoxib Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Celecoxib Market Size by Country (M USD)
Figure 11. Celecoxib Sales Share by Manufacturers in 2023
Figure 12. Global Celecoxib Revenue Share by Manufacturers in 2023
Figure 13. Celecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Celecoxib Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Celecoxib Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Celecoxib Market Share by Type
Figure 18. Sales Market Share of Celecoxib by Type (2019-2024)
Figure 19. Sales Market Share of Celecoxib by Type in 2023
Figure 20. Market Size Share of Celecoxib by Type (2019-2024)
Figure 21. Market Size Market Share of Celecoxib by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Celecoxib Market Share by Application
Figure 24. Global Celecoxib Sales Market Share by Application (2019-2024)
Figure 25. Global Celecoxib Sales Market Share by Application in 2023
Figure 26. Global Celecoxib Market Share by Application (2019-2024)
Figure 27. Global Celecoxib Market Share by Application in 2023
Figure 28. Global Celecoxib Sales Growth Rate by Application (2019-2024)
Figure 29. Global Celecoxib Sales Market Share by Region (2019-2024)
Figure 30. North America Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Celecoxib Sales Market Share by Country in 2023
Figure 32. U.S. Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Celecoxib Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Celecoxib Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Celecoxib Sales Market Share by Country in 2023
Figure 37. Germany Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Celecoxib Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Celecoxib Sales Market Share by Region in 2023
Figure 44. China Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Celecoxib Sales and Growth Rate (Kilotons)
Figure 50. South America Celecoxib Sales Market Share by Country in 2023
Figure 51. Brazil Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Celecoxib Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Celecoxib Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Celecoxib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Celecoxib Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Celecoxib Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Celecoxib Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Celecoxib Market Share Forecast by Type (2025-2030)
Figure 65. Global Celecoxib Sales Forecast by Application (2025-2030)
Figure 66. Global Celecoxib Market Share Forecast by Application (2025-2030)
